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Podocyte injuries exacerbate mesangial proliferative glomeru- Thy 1.1 nephritis induced by single injection of anti-
lonephritis. Thy 1.1 antibody are reversible and normalized by four
Background. From the observations of morphology seen in weeks, the model is not available for the investigationearly phases of the experimental models of the irreversible
of the mechanisms of the progression of mesangial alter-mesangial proliferative glomerulonephritis, we hypothesized
ations to the end stage of glomerulus. To investigatethat podocyte injury is one of the important factors in bringing
upon irreversible glomerular alterations. To verify this hypoth- these progressive mechanisms, we established two mod-
esis, we investigated whether podocyte injury induced by puro- els of irreversible mesangial alterations with anti-Thy 1.1
mycin aminonucleoside (PAN) injection affects the mesangial monoclonal antibody (mAb) 1-22-3 [5, 6]. The first modelalterations of anti-Thy 1.1 glomerulonephritis.
of irreversible mesangial alterations is induced by twoMethods. Female Wistar rats were injected with 0.5 mg
consecutive injections of mAb 1-22-3 with an interval ofmonoclonal antibody (mAb) 1-22-3 five days after the injection
of 10 mg or 5 mg/100 g body weight (BW) of puromycin amino- two weeks, and the second one is induced by the injection
nucleoside (PAN), and sacrificed at 7 days or 8 weeks after of mAb 1-22-3 to uninephrectomized rats. We have been
the mAb 1-22-3 injection.
trying to identify the essential factor that brings uponResults. Consecutive injections of 10 mg/100 g BW of PAN
irreversible mesangial alterations using these irreversibleand mAb 1-22-3 caused the irreversible mesangial alteration
with persistent proteinuria (at week 8, proteinuria 100.3  models (abstract; Kawachi et al, J Am Soc Nephrol 9:
57.8 mg/24 h, matrix score 1.13  0.52, collagen type I score 459A, 1998) [7, 8]. One of the common factors of these
2.04 0.53, mRNA for collagen type I 227 79% to the group models is that the podocyte was already injured at the
with a single injection of 1-22-3). Although single injection of
phase of mesangiolysis induced by the final injection of5 mg/100 g BW of PAN was not capable of inducing abnormal
mAb 1-22-3. In the two consecutive injections model,proteinuria, consecutive injections of 5 mg/100 g BW of PAN
and mAb 1-22-3 also caused irreversible mesangial alteration podocyte alterations such as the effacement of the foot
and persistent proteinuria. processes caused by the first injection of mAb 1-22-3
Conclusions. Podocyte injury might be an important factor were still observed at the second mesangiolysis causedthat exacerbates mesangial proliferation and mesangial matrix
by the second injection of mAb 1-22-3. This fact meansexpansion. The irreversible mesangial alterations caused by
that the second mesangiolysis occurred under the injuredconsecutive injections of PAN and mAb 1-22-3 may be a novel
model that could be used to analyze the mechanism of progres- podocytes. In the uninephrectomized model, podocytes
sive mesangial alteration. were considered to be over functioning with the increased
glomerular filtration derived from the uninephrectomy,
which means that mesangiolysis occurred under the highly
Anti-Thy 1.1 glomerulonephritis is widely used for stressed podocytes. Some reports have suggested that the
clarifying the mechanism of the development of mesan- primary damage of the podocyte might be involved in the
gial proliferative glomerulonephritis [1–4]. However, be- progression of mesangial alterations in the experimental
cause the mesangial alterations of the standard type of [9, 10] and clinical studies [11]. Recently, Shih et al re-
ported that mesangial cell proliferation and the matrix
expansion were observed in the knockout (k/o) mouse ofKey words: puromycin aminonucleoside, anti-Thy 1.1 monoclonal anti-
body, nephrin, podoplanin. CD2 associated protein (CD2AP) [12]. These mesangial
alterations are considered to be brought on by the dys-Received for publication December 28, 2000
function of the podocytes, because CD2AP is reportedand in revised form July 5, 2001
Accepted for publication July 9, 2001 to sustain the function of nephrin, which is a functional
molecule of a slit diaphragm. From all of these observa- 2001 by the International Society of Nephrology
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tions, we hypothesized that podocyte dysfunction espe-
cially at the phase of mesangiolysis exacerbates the con-
sequent mesangial proliferation and matrix expansion.
To verify this hypothesis, puromycin aminonucleoside
(PAN) was chosen as a drug for the induction of podo-
cyte injury, because PAN is reported to have a specific
toxicity to podocytes and PAN nephropathy is widely
used as a model for human minimal change nephrotic
syndrome (MCNS) and focal segmental glomeruloscle-
rosis (FSGS). We designed an experimental protocol in
which podocyte injury was induced by PAN injected 5
days before an anti-Thy 1.1 mAb 1-22-3 injection. Podo-
cyte injuries evaluated with expressions of podoplanin
and nephrin, and with the effacement of the foot pro-
cesses were already observed on day 5 after the PAN
injection. Thus, in this experimental protocol, mesangio-
lysis occurred under the circumstance of the injured po-
docytes. We clearly demonstrated here that the pretreat-
ment of PAN exacerbated mesangial proliferation and
the consequent mesangial matrix expansion. Severe mes-
angial alterations with persistent proteinuria were still
detected at 8 weeks after the disease induction in rats
pretreated with PAN. The novel chronic model induced
by the consecutive injections of PAN and mAb 1-22-3
may be useful for clarifying the progressive mechanisms Fig. 1. Experimental protocols of experiments 2 and 3. Twenty-four-
hour urine samples were collected on days 1, 4, 1, 3, 5, 7, 14, 21,of mesangial proliferative glomerulonephritis.
28, 35, 42, 49, and 56 after the mAb 1-22-3 injection in experiment 3.
METHODS
Animals
(-SMA), anti-collagen type I, and anti-rat endothelial
Specific pathogen-free female Wistar rats (6 weeks cell (RECA1) antibody, and anti-leukocyte common an-
old) were purchased from Charles River Japan (Atsugi, tigen (OX-1) on day 5 were examined. The kidney index
Japan). All animal experiments conformed to the Na- was calculated by the formula of kidney weight (g)/BW
tional Institutes of Health Guide for the Care and Use
(g) 100. mRNA expressions of nephrin and podoplanin
of Laboratory Animals.
on day 5 were examined by semiquantitative reverse
transcriptase-polymerase chain reaction (RT-PCR).Experimental protocol
Experiment 2: Early findings of glomerular alterationsExperiment 1: Glomerulonephropathy with a PAN in-
of rats with consecutive injections of PAN and anti-jection. Five rats of each group received an intravenous
Thy 1.1 mAb 1-22-3. The experimental protocol is sum-injection of 1.0 mL of phosphate-buffered saline (PBS)
marized in Figure 1. Mesangial proliferative glomerulo-containing PAN 10 mg, 5 mg, or only saline/100 g body
nephritis was induced by an intravenous injection withweight (BW). Rats from each group were sacrificed at 5
1.0 mL of PBS containing 0.5 mg of mAb 1-22-3 fivedays or 10 days after the injection. 24-hour urine samples
days after the injection of PAN 10 mg/100 g BW (N from the rats at 1, 3, 5, and 10 days after the injection
5). As a control, 5 rats were injected with 0.5 mg of mAbof PAN were collected in a metabolic cage. The amount
1-22-3 five days after the injection of PBS, and 5 ratsof urinary protein excretion was measured by the Brad-
were injected with PBS five days after the injection offord method (Bio-Rad, Oakland, CA, USA). The right
PAN 10 mg/100 g BW. mAb 1-22-3 was prepared askidney was removed, weighed, and used to prepare the
described previously [13, 14]. All rats were sacrificed attotal glomerular RNA. Half of the left kidney was cut
7 days after the last injection. LM findings and IF findingsinto portions and used for assessment by light microscopy
of SMA, collagen type I, OX-1, ED-1 and anti-RECA1(LM), electron microscopy (EM), and immunofluores-
were examined.cence microscopy (IF). The others were also used to
Experiment 3: Long term observations of glomerularprepare the total glomerular RNA. LM, EM findings
alterations induced by consecutive injections of PAN andand IF findings with anti-nephrin, anti-podoplanin, anti-
3 integrin, anti-podocalyxin, anti--smooth muscle actin anti-Thy 1.1 mAb 1-22-3. The experimental protocol is
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Fig. 2. Protein excretion on the tenth day after several doses of puro-
mycin aminonucleoside (PAN) injection. Over 300 mg/day of protein-
uria (336.7  87.6 mg/day) appeared in rats injected with 10 mg/100 g
body weight (BW) of PAN, while no abnormal proteinuria was detected
in rats injected with 5 mg/100 g BW of PAN. Each value is expressed
as mean  SD (N  5).
Table 1. Mesangial findings, recruitment of inflammatory cells,
and kidney index after puromycin aminonucleoside (PAN)
injection (day 5)
PAN 10 mg PAN 5 mg PAN 0 mg
Parameters (N5) (N5) (N5)
Matrix score 0.0530.065 0.0210.028 0.0210.032
-SMA score 0.0140.027 0.0200.028 0.0130.028
Collagen I score 0.0320.039 0.0390.048 0.0180.041
OX-1 positive cells
Glomerular 1.430.13 1.170.43 1.010.46
Interstitial 77.57.4 80.014.9 65.724.6
Kidney index 0.4890.034 0.4700.036 0.4660.063
Abbreviations are: -SMA, -smooth muscle actin; OX-1, anti-leukocyte com-
mon antigen.
summarized in Figure 1. A total of 28 rats were divided
into the following six groups. 5 rats each were injected
Fig. 3. Electron micrographs on the fifth day after PAN injection.with 1.0 mL of PBS containing 0.5 mg of mAb 1-22-3
Partial effacement of foot processes (arrows) was detected in rats with
intravenously 5 days after the injection of PAN 10 mg/ the injection of PAN 5 mg/100 g BW (B). Edema of podocytes (P) and
extensive effacement of foot processes (arrows) were detected in rats100 g BW (group 1), with the same amount of mAb
with the injection of PAN 10 mg/100 g BW (C). (A; normal rat finding)1-22-3 five days after the injection of PBS (group 2),
(8000)
with PBS 5 days after the injection of PAN 10 mg/100 g
BW (group 3), with PBS twice in an interval of 5 days
(group 4), or, with 0.5 mg of mAb 1-22-3 intravenously
5 days after the injection of PAN 5 mg/100 g BW (group ide (TG) levels were measured. Creatinine clearance
(CCr) was calculated using the following formula: [CCr5). Three rats were injected with PBS 5 days after the
injection of PAN 5 mg/100 g BW (group 6). All rats (mg/min/kg BW)  urine creatinine (mg/dL)  urine
volume (mL) 1/serum creatinine (SCr; mg/dL) 1/1440were sacrificed on the 56th day after the last injection.
Twenty-four–hour urine samples from the rats 1 and 4 (min)/kg BW]. The kidney index was calculated by the
formula of kidney weight (g)/BW (g)  100. LM anddays after the injection of PAN, and 1, 3, 5, 7, 14, 21,
28, 35, 42, 49, and 56 days after the mAb 1-22-3 injection EM findings and IF findings of -SMA, collagen type I,
collagen type IV, laminin, OX-1 and anti-RECA1 werewere collected. Protein concentrations of urine samples
were determined by the Bradford method. Serum creati- examined. mRNA expression of collagen type I was ex-
amined by RT-PCR.nine, BUN, total protein, total cholesterol, and triglycer-
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Fig. 4. Immunofluorescence micrographs of nephrin and podoplanin on the fifth day after PAN injection. The stainings of nephrin (C) and
podoplanin (F ) in normal rat glomeruli were observed as a linear-like pattern. The stainings of nephrin (A) and podoplanin (D) were significantly
decreased in rats injected with 10 mg/100 g BW of PAN. Decreased stainings of nephrin (B) and podoplanin (E) were detected in rats injected
with 5 mg/100 g BW of PAN (400).
Morphological and immunohistochemical studies tions were incubated with anti-SMA antibody (Sigma, St.
Louis, MO, USA), anti-rat collagen type I antibody (Chem-For light microscopy, part of the kidney was fixed with
icon, Temecula, CA, USA), anti-rat collagen type IV anti-Carnoy solution, embedded in paraffin and a section
body (Cosmo Bio, Tokyo, Japan), anti-laminin antibodywas stained with periodic acid-Schiff (PAS). Mesangial
(American Research Products, Belmont, MA, USA), andmatrix expansion was analyzed semiquantitatively using
then stained with FITC-conjugated anti-mouse IgG2agrades 0 to 4 as described by Raij, Azar and Keane [15].
(for anti--SMA), FITC-conjugated anti-rabbit IgG (forThe total number of cells in the glomeruli was counted
anti-rat collagen type I and anti-rat collagen type IV,in a blind protocol and computed for 30 glomeruli for
Southern Biotechnology Associates, Birmingham, AL,
each kidney. USA), and FITC-conjugated anti-mouse IgG1 (for anti-
For electron microscopy, a part of the renal cortex laminin; Southern Biotechnology Associates), respec-
from each rat was cut into small pieces and fixed in 2.5% tively. The intensity of -SMA and collagen type I stain-
glutaraldehyde in 0.1 mol/L phosphate buffer (PB) for ing was scored as the method described by Floege et al
several days at 4C. After washing in PB and post-fixing [16]. To identify the subpopulation of inflammatory cells
in 1% OsO4 for two hours, the fixed material was dehy- recruited in the glomeruli, the cryostat sections were in-
drated through an ethanolpropylene oxide series and cubated with anti-OX-1 (Serotec, Oxford, JE, UK), or
embedded in Araldite M. Ultrathin sections were pre- anti-ED1 (Chemicon), and then stained with FITC-con-
pared and stained with uranyl acetate and lead citrate, jugated anti-mouse IgG1. The number of positive cells
and examined under a JEOL 1200EX electron micro- for these markers was counted in more than 30 full-sized
scope (Tokyo, Japan). glomeruli. In the interstitium 30 randomly selected high
For immunofluorescence microscopy, renal tissue was power fields, each 0.5 mm in diameter (that is, covering
quickly frozen in n-hexane and cooled to 70C. Four- a total area of 6 mm2), were evaluated. To identify the
degree of podocyte injury the cryostat sections were in-micrometer thick sections were cut by cryostat. These sec-
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Table 2. Mesangial findings and recruitment of inflammatory cells
after monoclonal antibody (mAb) 1-22-3 injection (day 7)
PAN 10 mg  PBS  PAN 10 mg 
mAb 1-22-3 mAb 1-22-3 PBS
Parameters (N5) (N5) (N5)
Matrix score 0.650.30b 0.140.09 0.180.41
-SMA score 2.280.17b 1.600.20 0.0450.025
Collagen I score 0.210.16 0.0780.093 0.0450.043
OX-1 positive cells (glom.) 14.23.6 11.22.4 2.90.8
ED-1 positive cells (glom.) 0.900.33 0.470.33 0.170.24
Total cell count (glom.) 72.08.1a 59.65.7 55.63.3
a P  0.05 vs. PBS  mAb 1-22-3 group
b P  0.01 vs. PBS  mAb 1-22-3 group
volume of 20 mL, which contained 20 mmol/L Tris-HCl
(pH 8.4), 50 mmol/L KCl, 2.5 mmol/L MgCl2, 1 mmol/L
each of dATP, dCTP, dGTP and dTTP, 0.5 mg oligo(dT)
and 50 U reverse transcriptase (SuperScript II; Gibco
BRL). At the end of the incubation, samples were heated
at 90C for five minutes to eliminate the transcriptase ac-
tivity. Then, 3 	L of cDNA were amplified in a 50 	L to-
tal volume of PCR buffer containing 10 mmol/L Tris-HCl
(pH 8.3), 50 mmol/L KCl, 1.5 mmol/L MgCl2, 200 mmol/L
Fig. 5. mRNA expressions of nephrin and podoplanin on the fifth day each dATP, dCTP, dGTP and dTTP, 0.4 mmol/L each of
after PAN injection. RT-PCR amplification of nephrin and podoplanin the 5
 and 3
 primers and 2.5 U heat-activatable Taq DNAtranscripts was performed using the total RNA extracted from the
polymerase (AmpliTaq Gold; Perkin-Elmer, Foster, CA,isolated glomeruli of pooled kidneys of rats from each group. Ratios
of the densitometric signals of nephrin or podoplanin and the internal USA). The primers of nephrin, collagen type I and
control (GAPDH) were analyzed. Representative agarose gel electro- GAPDH were designed according to the published se-phoretic patterns from one of three experiments are shown at the top,
quence [17, 19]. The primers of podoplanin were designedand the bottom data are shown as ratios relative to normal rat findings
and are expressed as mean  SD of three independent experiments. based on their sequences (sense 5
-GAGCGTTTGGTT
mRNA expression of nephrin and podoplanin clearly decreased in rats CTGGGACTCA-3
, antisense 5
-AGGAAGAGG ATG
injected with 10 mg/100 g BW of PAN.
GGGAACAGG-3
). Amplification was carried out us-
ing the PC-800 programmable temperature control sys-
tem (Astec, Fukuoka, Japan) through 20 to 30 cycles of
denaturation at 95C for 30 seconds, annealing at individ-cubated with anti-nephrin (prepared as described previ-
ual temperatures for 30 seconds, and extension at 72Cously [17]), anti-podoplanin (prepared by the immuniza-
for one minute. The optimum number of amplificationtion of a nephritogenic site of 20 amino acids residue
cycles used for the semiquantitative PCR was chosen[18]), anti-3 integrin (Chemicon), anti-podocalyxin (kindly
based on the preliminary trial in the linear phase ofdonated by Dr. A. Miettinen, University of Helsinki, Hel-
amplification. The PCR products were electrophoresedsinki, Finland), and stained with FITC-conjugated anti-
on 1.2% agarose gel containing 0.0001% ethidium bro-rabbit (for anti-nephrin, anti-podoplanin, anti-3integrin)
mide in TAE buffer, and band intensities were deter-and FITC-conjugated anti-mouse IgG (for anti-podo-
mined by image analysis using a Macintosh computercalyxin). To identify the endothelial cell alterations the
and the Densitometry program (Densitograph, ATTO,
cryostat sections were incubated with anti-RECA1 (Sero- Tokyo, Japan). All results were corrected for the amount
tec), and stained with FITC-conjugated anti-mouse IgG1. of mRNA of GAPDH as an internal standard. The data
are shown as ratios relative to normal rat expressionSemiquantitative RT-PCR
and are expressed as mean  SD of these independent
Glomeruli were isolated from the kidneys pooled from experiments.
the same group. The total RNA was extracted from iso-
lated glomeruli by TRIZOL (GIBCO BRL, Gaithers- Statistical analysis
burg, MD, USA) and stored at 70C before use. RNA Statistical significance was evaluated using the un-
was quantified by absorbance at 260 nm. First strand paired t test or the Mann-Whitney U test. All values
cDNA was synthesized by transcribing the RNA from were expressed as the mean  SD. Differences at P 
each group by using a commercial kit (Superscript pre- 0.05 were considered significant. Data were analyzed
amplification system; GIBCO BRL). Five micrograms using StatView for Macintosh (Abacus Concepts, Berke-
ley, CA, USA).of RNA were incubated at 42C for 50 minutes in a final
Fig. 6. Light micrographs (LM) and immunofluorescence (IF) micrographs of -smooth muscle actin (SMA) on the seventh day after consecutive
injections of PAN and mAb 1-22-3. Different stages of glomerular alterations were observed in rats with consecutive injections of 10 mg/100 g
BW of PAN and mAb 1-22-3 (A). Mesangial proliferation was observed in some glomeruli (small arrows). In other glomeruli, ballooning was still
detected (arrowheads). Interstitial edema and dilated tubules with hyaline casts were observed (large arrows). The alterations in rats with a single
injection of mAb 1-22-3 were milder than the findings of the consecutive injections group, although ballooning (arrowheads) and mesangial cell
proliferation (small arrow) were observed in some glomeruli (B). SMA IF staining in the mesangial area in the consecutive injections group (D)
was more extensive than that in the mAb 1-22-3 single injection group (E). Neither mesangial alterations or stainings of SMA were detected in
rats with a single injection of 10 mg/100 g BW of PAN (C and F ) (A  C, 200; D  F, 400).
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RESULTS
Experiment 1: Glomerulonephropathy with
a PAN injection
The amount of proteinuria ten days after the injection
of PAN is shown in Figure 2. Although massive protein-
uria (336.7  87.6 mg/24 h) was detected after the injec-
tion of PAN 10 mg/100 g BW, no abnormal proteinuria
was found in rats injected with 5 mg/100 g BW of PAN.
Any mesangial alterations evaluated by the matrix score,
IF intensity scores of -SMA and collagen type I were
not detected after any doses of the PAN injection. Nei-
ther OX-1 positive cell infiltration in the glomeruli or
interstitium was detected in any group. No difference in
the kidney index was detected between the groups. LM
findings, IF findings of -SMA, collagen type I, OX-1, and
Fig. 7. Kinetics of urinary protein excretion of rats with consecutivekidney index after several doses of the PAN injection
injections of PAN and mAb 1-22-3. Severe proteinuria was detectedare summarized in Table 1 (day 5). No difference in the
in rats with consecutive injections of PAN and mAb 1-22-3. The amount
RECA1 staining pattern was detected between the groups. of urinary protein on day 1 of rats with consecutive injections of 10 mg/
100 g BW of PAN and mAb 1-22-3 was significantly higher than thatPartial effacement of foot processes was detected in rats
of rats with a single injection of 10 mg/100 g BW of PAN, althoughwith the injection of PAN 5 mg/100 g BW (Fig. 3B). proteinuria was not detected yet on day 1 of rats with a single injection
Edema of podocytes and extensive effacement of foot of mAb 1-22-3. Abnormal proteinuria was still detected at 2 months
after the disease induction in both groups treated with consecutiveprocesses were detected in rats with the injection of PAN
injections of 10 mg of PAN and mAb 1-22-3, and of 5 mg of PAN and10 mg/100 g BW (Fig. 3C). IF staining of nephrin and mAb 1-22-3. Note that although no abnormal proteinuria was detected
podoplanin in the normal group was a linear pattern of at any time in rats with a single injection of 5 mg/100 g BW of PAN,
severe and persistent proteinuria was detected in rats with consecutivecontinuous fine granules (Fig. 4 C, F). The nephrin stain-
injections of 5 mg/100 g BW of PAN and mAb 1-22-3. *P  0.05 vs.ing pattern shifted to a mottled granular pattern in the rats with a single injection of 10 mg/100 g BW of PAN; #P  0.05,
rats after the injection of PAN 10 mg/100 g BW (Fig. 4A) ##P  0.01 vs. rats with a single injection of mAb 1-22-3. Each value
is expressed as mean SD. Symbols are: () PAN 10 mgmAb 1-22-3;and 5 mg (Fig. 4B). The staining intensity of podoplanin
() PAN 5 mg  mAb 1-22-3; ( ) phosphate buffered saline (PBS) of rats after the injection of PAN 5 mg became weaker mAb 1-22-3; () PAN 10 mg  PBS; () PAN 5 mg  PBS; ()
(Fig. 4E). Podoplanin staining of rats after the injection PBS  PBS.
of PAN 10 mg almost disappeared (Fig. 4D). No difference
in the staining intensity of 3integrin and podocalyxin
flammatory cells infiltration were more evident in thewas detected between the groups. Quantitative data of
consecutive injections with PAN 10 mg and the mAbmRNA expressions of nephrin and podoplanin on the
1-22-3 group (Fig. 6A) than in the single mAb 1-22-3fifth day are shown in Figure 5. mRNA expressions of
injection group (Fig. 6B). Broader staining of -SMA wasnephrin and podoplanin on the 5th day decreased in rats
observed in the consecutive injections group (Fig. 6D)injected with PAN 10 mg/100 g BW (nephrin, 54 16%;
than in the single mAb 1-22-3 injection group (Fig. 6E).podoplanin, 59  23% to normal rats).
Neither mesangial alterations nor -SMA staining was
Experiment 2: Early findings of glomerular alterations detected in rats with a single injection of 10 mg/100 g
of rats with consecutive injections of PAN and BW of PAN (Fig. 6 C, F). Although decreased staining
anti-Thy 1.1 mAb 1-22-3 of RECA1 was detected in the mAb 1-22-3 injection
groups, no differences of RECA1 staining intensity wereThe mesangial matrix score, the IF intensity scores of
observed between the single mAb 1-22-3 injection group-SMA and collagen type I, the numbers of total cells
and the group with consecutive injections of PAN andand, OX-1 or ED-1 positive cells in glomeruli 7 days after
mAb 1-22-3.the last injection are summarized in Table 2. Mesangial
alterations in rats with consecutive injections of PAN
Experiment 3: Long-term observations of glomerular10 mg and mAb 1-22-3 were more severe than those in
alterations induced by consecutive injections of PANthe single mAb 1-22-3 injection group (matrix score,
and anti-Thy 1.1 mAb 1-22-30.65  0.30 vs. 0.14  0.09, P  0.05; -SMA score,
2.28  0.17 vs.1.60  0.20, P  0.01; total cell count in The kinetics of urinary protein excretion is shown in
Figure 7. Although proteinuria was not detected inthe glomeruli, 72.0  8.1 vs. 59.6  5.7, P  0.05). Light
microscopic findings and IF findings of-SMA are shown group 3 (single injection of mAb 1-22-3) on day 1 after
the mAb 1-22-3 injection, the amount of urinary proteinin Figure 6. Ballooning of the mesangial area and in-
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Table 3. Glomerular and serological findings, kidney index, and recruitment of inflammatory cells after mAb 1-22-3 injection (day 56)
Group 1 Group 2 Group 3 Group 4 Group 5
Parameters PAN 10 mg  mAb 1-22-3 PAN 5 mg  mAb 1-22-3 PBS  mAb 1-22-3 PAN 10 mg  PBS PBS  PBS
Matrix score 1.130.52ad 0.450.08d 0.340.13c 0.100.05 0.050.01
-SMA score 0.780.30ad 0.390.13d 0.230.21 0.060.07 0.050.05
Collagen I score 2.040.52bd 0.960.39ad 0.220.31 0.010.03 0.040.05
24CCr ml/min kg BW 0.220.16b 0.710.56 0.961.46 1.221.09 2.140.82
Creatinine mg/dL 0.480.22 0.340.05 0.300 0.280.04 0.280.04
BUN mg/dL 32.710.0 28.24.1 30.12.7 34.74.8 34.65.7
Total protein mg/dL 6.20.3 6.00.3 6.20.4 6.60.3 6.50.2
TC mg/dL 143.053.5ad 101.435.4b 66.411.8 79.66.3b 64.49.2
TG mg/dL 230.4194.8bc 72.239.8 26.45.9 30.49.1 41.418.0
Kidney Index 0.6340.170cd 0.4940.090ab 0.3840.019 0.4660.044b 0.3690.038
OX-1 positive cells
Glomerular 4.330.37cd 3.461.23 3.120.53 3.361.12 3.120.54
Interstitial 362.185.1cd 280.943.4cd 102.624.2 98.925.8 82.322.9
Abbreviations are: mAb, monoclonal antibody; SMA, -smooth muscle actin; CCr, creatinine clearance; BUN, blood urea nitrogen; TC, total cholesterol; TG,
triglyceride.
a P  0.05 vs. PBS  mAb 1-22-3 group
b P  0.05 vs. PBS  PBS group
c P  0.01 vs. PBS  mAb 1-22-3 group
d P  0.01 vs. PBS  PBS group
on day 1 in group 1 (consecutive injections of PAN 10 PAN 5 mg and mAb 1-22-3 (group 2) were higher than
those of group 3 (collagen type I score, 0.96  0.38,mg and mAb 1-22-3) was significantly higher than that
in group 4 (single injection of PAN 10 mg; 263.9  125.4 P  0.05; compared with group 3, OX-1 positive cells in
vs. 81.0  107.8 mg/day; P  0.05). Urinary protein interstitium 280.9  43.4, P  0.01). No differences of
excretions of groups 3 and 4 decreased gradually and RECA1 staining were observed between group 3 and
were normalized by four weeks after the injection. How- group 1 or 2. The representative findings of light micros-
ever, abnormal proteinuria persisted for two months in copy on the 56th day are shown in Figure 8. Severe glo-
group 1. No abnormal proteinuria was observed at any merular alterations and tubulointerstitial injuries were
time in group 6 (single injection of PAN 5 mg), but observed on the 56th day in rats with consecutive injec-
proteinuria in group 2 (consecutive injections of PAN 5 tions of 10 mg/100 g BW of PAN and mAb 1-22-3 (Fig. 8
mg and mAb 1-22-3) peaked on day 5 (213.8  46.7 mg/ A, B). Glomerular and tubulointerstitial alterations were
day) and continued for two months (day 56, 62.5  also observed in rats with 5 mg/100 g BW of PAN and
58.4 mg/day). Mesangial alterations evaluated by the ma- mAb 1-22-3 (Fig. 8C). LM findings of rats with a single
trix score, IF intensity scores of -SMA and collagen injection of mAb 1-22-3 (Fig. 8D) or 10 mg/100 g BW
type I, creatinine clearance, biochemical data [serum of PAN (Fig. 8E) were almost normal. EM findings of
creatinine, blood urea nitrogen (BUN), total protein, group 1 are shown in Figure 9. Podocyte alterations such
total cholesterol, and triglyceride (TG)], kidney index, as edema cytoplasm and effacement of foot processes,
and the number of OX-1 positive cells in the glomeruli or and the expansion of mesangial matrix were detected.
interstitium on the 56th day are summarized in Table 3. The EM also showed a condensation and meandering
Mesangial alterations evaluated by the matrix score, IF of the lamina densa portion of the basement membrane.
intensity scores of -SMA and collagen type I were more Representative IF findings are shown in Figure 10. Stain-
severe in group 1 than in group 3 (matrix score, 1.13  ings of collagen type I (Fig. 10 A–C), collagen type IV
0.52 vs. 0.34  0.13, P  0.05; SMA score, 0.78  0.30 (D–F), laminin (H–I) were increased not only in group
vs. 0.23  0.21, P  0.05; collagen type I score, 2.04  1 (A, D, G), but also in group 2 (B, E, H). mRNA
0.52 vs. 0.22  0.31, P  0.01). Average values of the expression of collagen type I is shown in Figure 11.
kidney index and total cholesterol were higher in group mRNA expression of collagen type I in group 1 was
1 than in group 3 (kidney index, 0.634 0.170 vs. 0.384 higher than that of rats with a single injection of mAb
0.019, P  0.05; total cholesterol, 143.0  53.5 vs. 66.4  1-22-3 on the 56th day (2.27  0.79 times the group with
11.8 mg/dL, P 0.05). A larger number of OX-1 positive a single injection of mAb 1-22-3).
inflammatory cells in the glomeruli and interstitium were
observed in group 1 than in group 3 (glomeruli, 4.33 
DISCUSSION0.37 vs. 3.12  0.53, P  0.01; interstitium, 362.1  85.1
The multiple roles of the podocyte in maintaining glo-vs. 102.6  24.2, P  0.01). Furthermore, the collagen
merular function have recently been emphasized [20–22].type I score and the number of OX-1 positive cells in
the interstitium in rats with consecutive injections of It is considered that podocytes contribute to maintaining
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Fig. 8. Light micrographs on the 56th day after consecutive injec-
tions of PAN and mAb 1-22-3. Severe glomerular alterations such
as the mesangial matrix expansion (arrows, A) and crescent formation
(arrowheads, A) and tubulointerstitial injuries such as infiltration of
inflammatory cells (arrows, B) were observed on the 56th day in rats
with consecutive injections of 10 mg/100 g BW of PAN and mAb
1-22-3. The mesangial matrix expansion (arrows) was also observed
in rats with the injection of 5 mg/100 g BW of PAN and mAb 1-22-3
(C). LM findings of rats with a single injection of mAb 1-22-3 (D)
or 10 mg/100 g BW of PAN (E) were almost normalized. (A, C 
E, 200; B, 100)
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tractile function of podocytes prevented the expansion of
the mesangial area, and that the decrease of the podocyte
function contributed to the irreversible mesangial alter-
ations.
Anti-Thy 1.1 mAb 1-22-3 has a higher potential to
induce mesangial alterations than other reported anti-
Thy 1.1 antibodies [23]. mAb 1-22-3 binds to the limited
mesangial cell surface facing the endothelial cell and
causes mesangiolysis [24]. PAN is understood to have a
specific toxicity to podocytes. PAN nephrosis is widely
used as a model for human MCNS by a single injection
and FSGS by multiple injections. In the beginning of
this study, we confirmed that PAN treatment did not
affect the mesangial cell, endothelial cell, nor the in-
flammatory cells responses. The precise mechanism of
the toxicity of PAN has not been fully clarified yet, al-
though it has been reported that oxygen radicals that
are produced during the metabolism of PAN contribute
to the podocyte injury [25, 26]. Because the podocyte
injuries were already detected on day 5 after the injection
of PAN, this time point was chosen for the induction of
Thy 1.1 nephritis. In this experimental protocol, mesangi-
olysis occurs in the circumstance of the injured podo-
cytes.
This study clearly demonstrates that pretreatment with
PAN exacerbates the early phases of mesangial cell pro-
liferation and the mesangial matrix expansion (Table 2
Fig. 9. Electron micrograph on the 56th day after consecutive injec- and Fig. 6) just after mesangiolysis. Severe mesangial
tions of PAN and mAb 1-22-3. Podocyte alterations such as edema alterations were still detected in rats with consecutivecytoplasm (P) and effacement of foot processes (arrows), and the expan-
injections of PAN and mAb 1-22-3 on 56th day aftersion of mesangial matrix (MM) were detected. Condensation (arrow-
heads) and the meandering running of lamina densa of basement mem- disease induction, although mesangial alterations in rats
brane also were detected (8000). with a single injection of mAb 1-22-3 were normalized
by 56th day (Figs. 8 to 10 and Table 3). Furthermore,
we demonstrated that glomerular mRNA expression of
collagen type I increased on 56th day in rats with consec-the barrier function of the glomerular capillary wall, and
that the dysfunction of the podocyte slit diaphragm leads utive injections of PAN and mAb 1-22-3 (Fig. 11). These
findings indicated that the pretreatment of PAN priorto proteinuria. It also is reported that podocytes play
a critical role in maintaining the normal structure of to the injection of mAb 1-22-3 caused irreversible mesan-
gial alterations. Our study also showed that the intersti-glomeruli. Electron microscopic findings of the early
phases of Thy 1.1 nephritis showed that some capillary tial injuries such as inflammatory cells infiltration and
fibrotic changes were induced in rats with consecutivewalls still maintained an intact structure even in the glo-
meruli whose mesangial cells were completely lysed. injections of PAN and mAb 1-22-3. It is conceivable that
the irreversible mesangial alterations and the persistentThese observations clearly showed that podocytes con-
tribute to the structural stability of glomerular capillar- proteinuria contributed to the development of the tubu-
lointerstitial alterations.ies. However, in the natural course of Thy 1.1 nephritis,
capillary walls were temporarily maintained by the con- In this study, the podocyte injuries caused by PAN
were evaluated not only by EM finding and the amounttractile function of podocytes, and then ballooning and
hypercellularity in the mesangial area were observed. of proteinuria, but also by the expressions of podoplanin
and nephrin. Effacement of podocyte foot processes wasWe succeeded in establishing the irreversible models
of mesangial alterations with anti-Thy 1.1 mAb 1-22-3. observed in both groups of PAN injection with 5 mg/
100 g BW and 10 mg/100 g BW of PAN. The immunohis-Ballooning and mesangial cell proliferation in the irre-
versible models were more severe and occurred more tological staining of nephrin and podoplanin dramati-
cally decreased with the treatment of 10 mg/100 g BWrapidly than those in the reversible model. In these irre-
versible models, the mesangiolysis occurred under the of PAN (Fig. 4), and that mRNA expressions for po-
doplanin and nephrin decreased (Fig. 5), although theinjured podocyte. Thus, we hypothesized that the con-
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Fig. 10. Immunofluorescence micrographs of
collagen type I (A–C), collagen type IV (D–F),
laminin (H–I). Stainings of collagen type I,
collagen type IV, laminin were increased not
only in group of consecutive injections of
10 mg/100 g BW of PAN and mAb 1-22-3
(A, D, G), but also in group of consecutive
injections of 5 mg/100 g BW of PAN and mAb
1-22-3 (B, E, H). Almost normal findings were
detected in group of single injection of mAb
1-22-3 (C, F, I) (400).
staining pattern of integrin was not significantly changed. cytes and tubular epithelial cells, and it is one of the most
important factors leading to the progression of kidney dis-Podoplanin is reported to be an essential molecule that
maintains the interdigitation of foot processes [18, 27]. ease [19, 33–37]. Our study found that consecutive injec-
tions of PAN and mAb 1-22-3 caused larger amounts ofNephrin is reported to be a critical molecule for main-
taining the barrier function of the podocyte slit dia- proteinuria than the total amount of the average values
of proteinuria induced by a single injection of PAN andphragm [17, 28–30]. Dysfunction of podoplanin and
nephrin and the consequent podocyte shape changes, a single injection of mAb 1-22-3 (Fig. 7). Severe protein-
uria is considered to contribute to the development ofsuch as the effacement of the foot processes, may attenu-
ate the contractile function of podocyte against the GBM the irreversible mesangial alterations. However, it is not
conceivable that proteinuria caused by PAN is the soledistention. To investigate the role of podoplanin and
nephrin in the progression of the mesangial alterations, critical element that exacerbates mesangial alterations,
because no abnormal proteinuria was detected in ratsfurther studies with the treatment of anti-podoplanin or
anti-nephrin antibody are necessary. injected with 5 mg/100 g BW of PAN at any time through-
out the experiment. Interestingly, pretreatment of 5 mg/Recently, some investigators proposed that the mesan-
gial disintegration was followed by endothelial injury 100 g BW of PAN prior to the mAb 1-22-3 injection
resulted in irreversible mesangial alterations in rats in-and the recovery of mesangial impairment was depen-
dent upon endothelial recovery [31, 32]. In the beginning jected with mAb 1-22-3. It should be noted that even
a minor podocyte injury, in which effacement of footof this study, we confirmed that PAN did not cause
the endothelial cell damage with anti-RECA1 antibody, processes and decreased expression of podoplanin and
nephrin were detected, but abnormal proteinuria was notbecause RECA 1 staining was reported to be a marker
of endothelial cell injury [31]. Pretreatment of PAN also detected, contributes to the development of irreversible
mesangial alteration. These findings suggest that minordid not affect the endothelial damage in rats with mAb
1-22-3 injection. These findings showed that PAN treat- podocyte injury could be a prognostic marker of mesan-
gial proliferative glomerulonephritis. The expression ofment caused podocyte damage without endothelial cell
injury. The finding that PAN treatment exacerbated the podoplanin and nephrin could be one of the candidates
for prognostic markers.mesangial injury indicated that the podocyte played a
critical role in the recovery of mesangial alterations. It Recently, some reports and reviews focusing on the
role of podocytes in the degenerative process of glomeru-is emphasized that proteinuria itself is harmful to podo-
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Floege et al have reported that FGF-2 derived from
podocytes may amplify the podocyte damage [42], and
that FGF-2 pretreatment exacerbated the mesangial al-
terations in Thy 1.1 nephritis [4]. These findings sug-
gested that not only the disorder of the podocyte func-
tions in maintaining the architectural structure, but also
some cytokines from podocytes might be involved in the
development of mesangial alterations. Expressions of
these podocyte-derived cytokines could be prognostic
markers of mesangial proliferative glomerulonephritis.
Because podocytes are accepted as post-mitotic cells,
they can easily have irreversible cell damage. These spe-
cific characters of podocytes strongly suggest that podo-
cyte damage is involved in the development of irrevers-
ible glomerular alterations. Some reports described
several findings of podocyte damage detected in different
types of human glomerular diseases [9, 11, 38]. We be-
lieve that analyses of the injuries of the mesangial cell
as well as analyses of the injuries of the podocyte are
important in predicting the prognosis of mesangial prolif-
erative glomerulonephritis. All of these findings suggest
that podocytes could be a target for treating several types
of glomerular diseases, including mesangial proliferative
glomerulonephritis. The irreversible glomerular alter-
ations with persistent proteinuria caused by the consecu-
tive injections of PAN and mAb 1-22-3 may be a novelFig. 11. Collagen type I mRNA expression on the 56th day after con-
secutive injections of PAN and mAb 1-22-3. RT-PCR amplification of model for the analyses of the pathogenesis of the human
collagen type I transcripts was performed using the total RNA extracted progressive glomerular disease. The model could be
from isolated glomeruli of pooled kidneys from rats in each group.
available for the development of new drugs for progres-Ratios of the densitometric signals of nephrin or podoplanin and the
internal control (GAPDH) were analyzed. The data are shown as ratios sive mesangial proliferative glomerulonephritis.
relative to the findings of the mAb 1-22-3 single injection group and In conclusion, consecutive injections of PAN and anti-
are expressed as mean  SD of three independent experiments (bot-
Thy 1.1 mAb 1-22-3 cause progressive mesangial alter-tom). The representative agarose gel electrophoretic patterns from one
of three experiments are shown at the top. mRNA expression of collagen ations with massive proteinuria. This study clearly dem-
type I of rats with consecutive injections of PAN 10mg and the mAb onstrates that minor podocyte injury, which did not show
1-22-3 group was higher than that of rats with a single injection of mAb
abnormal proteinuria, exacerbated the mesangial alter-1-22-3 on the 56th day after the disease induction.
ations. The irreversible mesangial alterations presented
here could be a novel model for clarifying the mecha-
nisms of the pathogenesis of progressive mesangial alter-
lus have been published [20–22, 38, 39]. Kriz et al re- ations.
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